国邦医药2025年第三季度净利润同比增长23.17%

Core Insights - Guobang Pharmaceutical reported a revenue of 1.444 billion yuan for Q3 2025, a year-on-year decrease of 5.39% [1] - The net profit attributable to shareholders was 215 million yuan, reflecting a year-on-year increase of 23.17% [1] - The net profit after deducting non-recurring gains and losses was 183 million yuan, up 7.87% year-on-year [1] Financial Performance - For the first three quarters of 2025, the company achieved a total revenue of 4.47 billion yuan, representing a year-on-year growth of 1.17% [1] - The net profit attributable to shareholders for the same period was 670 million yuan, showing a year-on-year increase of 15.78% [1] - The net profit after excluding non-recurring items for the first three quarters was 619 million yuan, which is a year-on-year growth of 9.59% [1]